Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

First launch for new indication of cabergoline

April 11, 1997

Selfadministration device for Imitrex available in the U.S.

April 9, 1997

Pharmacia & Upjohn's Rescriptor cleared by FDA

April 8, 1997

RPR's Tilade approved for pediatric use

April 8, 1997

Human skin equivalent approved in Canada

April 8, 1997

Clinical efficacy and safety of Aphthasol reviewed

April 7, 1997

Court rules in favor of Novopharm regarding generic ranitidine product

April 7, 1997

FDA clears Faulding's generic captopril

April 7, 1997

Shire's sustained-release carbamazepine deemed approvable by FDA

April 4, 1997

Budesonide cleared in Canada for Crohn's disease

April 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...